1 February 2022 - Thousands of people with cystic fibrosis are one step closer to accessing a 'lifesaving' drug, after it was recommended for inclusion on the Pharmaceutical Benefits Scheme .
The medication Trikafta has been credited with helping people with cystic fibrosis avoid lung transplants and live longer lives.